MEDICAL DESCRIPTION OF VINTOR 2000IU INJECTION
Vintor 2000 IU injection contains Erythropoietin alfa 2000IU a hematopoietic growth factor used in the treatment of anemia that occurs due to chronic kidney disease and cancer chemotherapy and in patients who are taking medicine to treat HIV. It produces its action by producing red blood cells by stimulating bone marrow.
VINTOR 2000 IU INJECTION USES
It is used in the treatment of anemia due to chronic kidney disease and cancer chemotherapy
VINTOR 2000IU INJECTION BENEFITS
Anemia due to chronic kidney diseases:
Chronic kidney disease is a loss of kidney function over a long period and this leads to anemia. Anemia occurs when your body does not have sufficient red blood cells to carry oxygen around the body. The use of this medicine boosts red blood cells and helps to reduce the symptoms of anemia such as tiredness and weakness.
Anemia due to cancer chemotherapy:
Chemotherapy causes many side effects one of the major side effects is anemia. The use of this medicine boosts the production of red blood cells in the bone marrow and controls the hemoglobin level in the blood.
VINTOR 2000IU INJECTION INDICATION
The Vintor 2000IU injection is prescribed for the following indications to anemia due to chronic kidney disease and cancer chemotherapy
MECHANISM OF ACTION OF VINTOR 2000IU INJECTION
Vintor 2000IU injection contains Erythropoietin alfa a hematopoietic growth factor that produces its action by boosting the bone marrow, which produces red blood cells.
HOW VINTOR 2000IU INJECTION WORKS
Vintor 2000IU injection contains Erythropoietin alfa 40mcg a hematopoietic growth factor that produces its action by boosting the bone marrow, which produces red blood cells.
VINTOR 2000IU INJECTION CONTRAINDICATION
- Do not take this medicine if you are allergic to Erythropoietin
- It is contraindicated to use this medicine in patients with uncontrolled hypertension
- Pure red cell aplasia begins after the treatment with Erythropoietin alfa
- It is contraindicated to use this medicine in cancer patients whose anemia is caused by other than chemotherapy